Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Dow
McKesson
Merck
Boehringer Ingelheim

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Topoisomerase I Inhibitors

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Oncol TOPOTECAN HYDROCHLORIDE topotecan hydrochloride INJECTABLE;INJECTION 091376-001 Nov 29, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Hong Kong TOPOTECAN HYDROCHLORIDE topotecan hydrochloride INJECTABLE;INJECTION 201166-001 Aug 8, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd TOPOTECAN HYDROCHLORIDE topotecan hydrochloride SOLUTION;INTRAVENOUS 206074-001 Nov 24, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Cipla TOPOTECAN HYDROCHLORIDE topotecan hydrochloride INJECTABLE;INJECTION 091199-001 Dec 1, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Novartis HYCAMTIN topotecan hydrochloride CAPSULE;ORAL 020981-002 Oct 11, 2007 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Accord Hlthcare TOPOTECAN HYDROCHLORIDE topotecan hydrochloride INJECTABLE;INJECTION 202351-001 Jun 26, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Colorcon
Boehringer Ingelheim
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.